India set to lead genomics revolution amid global patents expiry wave: Report
New Delhi, July 29 (IANS) India is uniquely positioned to capitalise on a global genomics revolution and a looming $300 billion patent expiry wave that is driving an aggressive wave of biopharma acquisitions, a report said on Wednesday.